Shang Song

Dr. Shang Song

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
YLYuxin Liu
Yuxin Liu
JLJinxing Li
Jinxing Li
Shang SongShang Song
Shang Song
JKJiheong Kang
Jiheong Kang
YTYuchi Tsao
Yuchi Tsao
ZBZhenan Bao
Zhenan Bao

23 June 2021 in Biomaterials
Verified
Journal Article
Closed access
Shang SongShang Song
Shang Song
KMKelly W. McConnell
Kelly W. McConnell
DADanielle Amores
Danielle Amores
ALAlexa Levinson
Alexa Levinson
HVHannes Vogel
Hannes Vogel
Paul GeorgePaul George
Paul George


13 April 2017 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
Shang SongShang Song
Shang Song
CBCharles Blaha
Charles Blaha
WMWillieford Moses
Willieford Moses
JPJaehyun Park
Jaehyun Park
NWNathan Wright
Nathan Wright
Shuvo RoyShuvo Roy
Shuvo Roy
Diffusion-based bioartificial pancreas (BAP) devices are limited by poor islet viability and functionality due to inadequate mass transfer resulting in islet hypoxia and delayed glucose–insulin kinetics. While intravascular ultrafiltration-based BAP devices possess enhanced glucose–insulin kinetics, the polymer membranes used in these devices provide inadequate ultrafiltrate flow rates and result in excessive thrombosis. Here, we report the silicon nanopore membrane (SNM), which exhibits a greater hydraulic permeability and a superior pore size selectivity compared to polymer membranes for use in BAP applications. Specifically, we demonstrate that the SNM-based intravascular BAP with ∼10 and ∼40 nm pore sized membranes support high islet viability (>60%) and functionality (<15 minute insulin response to glucose stimulation) at clinically relevant islet densities (5700 and 11 400 IE per cm2) under convection in vitro. In vivo studies with ∼10 nm pore sized SNM in a porcine model showed high islet viability (>85%) at clinically relevant islet density (5700 IE per cm2), c-peptide concentration of 144 pM in the outflow ultrafiltrate, and hemocompatibility under convection. These promising findings offer insights on the development of next generation of full-scale intravascular devices to treat T1D patients in the future.

24 March 2016 in Scientific Reports
Verified
Journal Article
Open access
Shang SongShang Song
Shang Song
GFGaetano Faleo
Gaetano Faleo
RYRaymond Yeung
Raymond Yeung
RKRishi Kant
Rishi Kant
APAndrew M Posselt
Andrew M Posselt
Shuvo RoyShuvo Roy
Shuvo Roy
Problems associated with islet transplantation for Type 1 Diabetes (T1D) such as shortage of donor cells, use of immunosuppressive drugs remain as major challenges. Immune isolation using encapsulation may circumvent the use of immunosuppressants and prolong the longevity of transplanted islets. The encapsulating membrane must block the passage of host’s immune components while providing sufficient exchange of glucose, insulin and other small molecules. We report the development and characterization of a new generation of semipermeable ultrafiltration membrane, the silicon nanopore membrane (SNM), designed with approximately 7 nm-wide slit-pores to provide middle molecule selectivity by limiting passage of pro-inflammatory cytokines. Moreover, the use of convective transport with a pressure differential across the SNM overcomes the mass transfer limitations associated with diffusion through nanometer-scale pores. The SNM exhibited a hydraulic permeability of 130 ml/hr/m2/mmHg, which is more than 3 fold greater than existing polymer membranes. Analysis of sieving coefficients revealed 80% reduction in cytokines passage through SNM under convective transport. SNM protected encapsulated islets from infiltrating cytokines and retained islet viability over 6 hours and remained responsive to changes in glucose levels unlike non-encapsulated controls. Together, these data demonstrate the novel membrane exhibiting unprecedented hydraulic permeability and immune-protection for islet transplantation therapy.

20 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Shang SongShang Song
Shang Song
DADanielle Amores
Danielle Amores
CCCheng Chen
Cheng Chen
KMKelly McConnell
Kelly McConnell
BOByeongtaek Oh
Byeongtaek Oh
Paul GeorgePaul George
Paul George
Human induced pluripotent stem cell-derived neural progenitor cells (hNPCs) are a promising cell source for stem cell transplantation to treat neurological diseases such as stroke and peripheral nerve injuries. However, there have been limited studies investigating how the dimensionality of the physical and electrical microenvironment affects hNPC function. In this study, we report the fabrication of two- and three-dimensional (2D and 3D respectively) constructs composed of a conductive polymer to compare the effect of electrical stimulation of hydrogel-immobilized hNPCs. The physical dimension (2D vs 3D) of stimulating platforms alone changed the hNPCs gene expression related to cell proliferation and metabolic pathways. The addition of electrical stimulation was critical in upregulating gene expression of neurotrophic factors that are important in regulating cell survival, synaptic remodeling, and nerve regeneration. This study demonstrates that the applied electrical field controls hNPC properties depending on the physical nature of stimulating platforms and cellular metabolic states. The ability to control hNPC functions can be beneficial in understanding mechanistic changes related to electrical modulation and devising novel treatment methods for neurological diseases.